Adoptive Immunotherapy for Hematological Malignancies Using T Cells Gene-Modified to Express Tumor Antigen-Specific Receptors

Accumulating clinical evidence suggests that adoptive T-cell immunotherapy could be a promising option for control of cancer; evident examples include the graft-vs-leukemia effect mediated by donor lymphocyte infusion (DLI) and therapeutic infusion of ex vivo-expanded tumor-infiltrating lymphocytes...

Descripción completa

Detalles Bibliográficos
Autor principal: Fujiwara, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276906/
https://www.ncbi.nlm.nih.gov/pubmed/25517545
http://dx.doi.org/10.3390/ph7121049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276906/
https://www.ncbi.nlm.nih.gov/pubmed/25517545
http://dx.doi.org/10.3390/ph7121049

Ejemplares similares